Research And Development Expense in CHF of Oculis Holding AG from 2020 to Q2 2024

Taxonomy & unit
ifrs-full: CHF
Summary
Oculis Holding AG quarterly/annual Research And Development Expense history and change rate from 2020 to Q2 2024.
  • Oculis Holding AG Research And Development Expense for the quarter ending June 30, 2024 was ₣16.5M, a 166% increase year-over-year.
  • Oculis Holding AG annual Research And Development Expense for 2023 was ₣29.2M, a 31.6% increase from 2022.
  • Oculis Holding AG annual Research And Development Expense for 2022 was ₣22.2M, a 132% increase from 2021.
  • Oculis Holding AG annual Research And Development Expense for 2021 was ₣9.57M, a 2.47% increase from 2020.
Research And Development Expense, Quarterly (CHF)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (CHF)
Research And Development Expense, YoY Annual Change (%)

Oculis Holding AG Quarterly Research And Development Expense (CHF)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 16.5M +10.3M +166% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-27
Q2 2023 6.2M Apr 1, 2023 Jun 30, 2023 6-K 2024-08-27

Oculis Holding AG Annual Research And Development Expense (CHF)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 29.2M +7.02M +31.6% Jan 1, 2023 Dec 31, 2023 20-F 2024-03-19
2022 22.2M +12.7M +132% Jan 1, 2022 Dec 31, 2022 20-F 2024-03-19
2021 9.57M +231K +2.47% Jan 1, 2021 Dec 31, 2021 20-F 2024-03-19
2020 9.34M Jan 1, 2020 Dec 31, 2020 20-F 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.